46 results
6-K
EX-10.1
BLRX
BioLineRx Ltd.
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
clinical programs, and for labeling and packaging. In addition, under the License Agreement with HST and Gloria, we expect the Licensee will in the future … and closures, production and process controls, packaging and labeling controls, holding and distribution, laboratory controls, records and reports
6-K
EX-99
BLRX
BioLineRx Ltd.
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
).
Inventory is measured at the lower of cost or net realizable value. The cost of inventories includes purchase costs, packaging and labeling costs, and other
6-K
EX-99
BLRX
BioLineRx Ltd.
30 Aug 23
Current report (foreign)
6:45am
materials (e.g. brochures, posters, giveaways), labeling and packaging materials, as well as material changes thereto, shall be subject to the approval … request for approval, provided, however, if the marketing promotion and packaging materials are the materials which have been provided by BioLine
6-K
EX-10.1
8dt11woeq
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
dm7lheg25 pj76
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
jnhu6ys9szyxrv1537
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-10.1
qxcgfkgq
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-99
wrpnna 84g
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
q878n
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
i5gh0g6qv98q
7 Feb 19
As Representative of the several Underwriters
12:00pm